Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ABVD, ADCC, adjacent, adjudicated, adriamycin, analytical, anticancer, arm, attack, baseline, bleomycin, brentuximab, British, broadly, bulk, Canadian, care, Celldex, cellular, center, chemistry, colon, commonly, contributor, correct, culture, dacarbazine, defucosylation, deliverable, density, description, died, distressed, easier, entirety, Euro, exhibit, Fabre, fashion, foregoing, forward, Frontline, fucose, fucosylation, fulfill, futility, GlaxoSmithKline, GLP, GSK, HDAC, IDMC, inactive, injunctive, insolvent, insufficient, internationally, involuntarily, Japan, join, kidney, labor, letter, line, lot, lung, lymph, mandated, matter, media, Medicament, Micromet, Mitigation, morphologic, mutual, neuropathy, orderly, outlicensed, overseen, pancreatic, panobinostat, pathway, peripheral, PFMP, pharmacovigilance, Pierre, pilot, postmarketing, Pound, preclinicalin, privacy, proactively, procedural, promptly, propriety, purport, RCC, reallocation, recommended, recordkeeping, Removed, residual, resupply, retreatment, Russia, sALCL, scientist, SEA, seizure, shorten, simpler, skin, skipped, standalone, substance, substitute, substituted, successor, sugar, surrogate, Takeda, tiered, timeframe, unaffected, uncured, unreasonable, vedotin, vinblastine, violated, voluntarily, week, wholly, wide
Removed:
adding, aggregating, allocated, animal, assistance, augment, Bulletin, Cabilly, circumstance, classification, CuraGen, customary, deducting, EITF, environment, escalating, exceeding, experiencing, extended, FAS, FIN, follicular, ICE, induction, initially, International, interpretation, investigator, managed, marginal, measuring, melanoma, membrane, preliminary, principally, Progenic, purpose, radiotherapy, recombinant, recording, reimbursed, SAB, scaleable, sublicensed, supplemented, toxic, unallocated, undelivered, vasculature, waived, zone
Filing tables
Filing exhibits
- 10-K Annual report
- 10.13 2000 Directors' Stock Option Plan
- 10.43 Employment Agreement
- 10.44 Employment Agreeement
- 10.48 Compensation Information for Executive Officers and Directors
- 10.49 Amendment to the Collaboration and License Agreement
- 10.50 Collaboration Agreement
- 10.51 Long Term Incentive Plan
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Section 302 Certification
- 31.2 Section 302 Certification
- 32.1 Section 906 Certification
- 32.2 Section 906 Certification
Related press release
SGEN similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-56670 and 333-148188) of Seattle Genetics, Inc., and in the Registration Statement on Form S-3 (File No. 333-159457) of Seattle Genetics, Inc. and in the related Prospectus, of our report dated March 11, 2010 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Seattle, Washington
March 11, 2010